5. Lee AS. The glucose-regulated proteins: stress induction and clinical
applications. Trends Biochem Sci 2001;26:504 – 10.
6. Hendershot LM. The ER function BiP is a master regulator of ER function. Mt
Sinai J Med 2004;71:289 – 97.

7. Yu Z, Luo H, Fu W, Mattson MP. The endoplasmic reticulum stress-responsive
protein GRP78 protects neurons against excitotoxicity and apoptosis: suppression
of oxidative stress and stabilization of calcium homeostasis. Exp Neurol 1999;
155:302 – 14.

8. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications.
Cancer Res 2007;67:3496 – 99.

9. Li J, Lee AS. Stress induction of GRP78/BiP and its role in cancer. Curr Mol
Med 2006;6:45 – 54.
10. Reddy RK, Mao C, Baumeister P, Austin RC, Kaufman RJ, Lee AS.
Endoplasmic reticulum chaperone protein GRP78 protects cells from apoptosis
induced by topoisomerase inhibitors: role of ATP binding site in suppression of
caspase-7 activation. J Biol Chem 2003;278:20915 – 24.

11. Ranganathan AC, Zhang L, Adam AP, Aguirre-Ghiso JA. Functional
coupling of p38-induced up-regulation of BiP and activation of RNA-dependent
protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant
carcinoma cells. Cancer Res 2006;66:1702 – 11.

12. Fu Y, Li J, Lee AS. GRP78/BiP inhibits endoplasmic reticulum BIK and
protects human breast cancer cells against estrogen starvation-induced apoptosis.
Cancer Res 2007;67:3734 – 40.

13. Pyrko P, Schonthal AH, Hofman FM, Chen TC, Lee AS. The unfolded
protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 2007;67:9809 – 16.
14. Ermakova SP, Kang BS, Choi BY, et al. ()-Epigallocatechin
gallate overcomes resistance to etoposide-induced cell death by targeting
the molecular chaperone glucose-regulated protein 78. Cancer Res 2006;66:
9260 – 9.
15. Ma Y, Hendershot LM. The role of the unfolded protein response in tumour
development: friend or foe? Nat Rev Cancer 2004;4:966 – 77.
16. Morris JA, Dorner AJ, Edwards CA, Hendershot LM, Kaufman RJ.
Immunoglobulin binding protein (BiP) function is required to protect cells from
endoplasmic reticulum stress but is not required for the secretion of selective
proteins. J Biol Chem 1997;272:4327 – 34.
17. Lee AS. The ER chaperone and signaling regulator GRP78/BiP as a monitor
of endoplasmic reticulum stress. Methods 2005;35:373 – 81.
18. Parney IF, Chang SM. Current chemotherapy for glioblastoma. Cancer J
2003;9:149 – 56.
19. Hida A, Kawakami A, Miyashita T, et al. Nitric oxide acts on the
mitochondria and protects human endothelial cells from apoptosis. J Lab Clin
Med 2004;144:148 – 55.
20. Nagasubramanian R, Dolan ME. Temozolomide: realizing the promise and
potential. Curr Opin Oncol 2003;15:412 – 8.
21. Mathijssen RH, Marsh S, Karlsson MO, et al. Irinotecan pathway genotype
analysis to predict pharmacokinetics. Clin Cancer Res 2003;9:3246 – 53.
22. Jamora C, Dennert G, Lee AS. Inhibition of tumor progression by
suppression of stress protein GRP78/BiP induction in fibrosarcoma B/C10ME.
Proc Natl Acad Sci U S A 1996;93:7690 – 94.
23. Dong D, Ni M, Li J, et al. Critical role of the stress chaperone GRP78/BiP in
tumor proliferation, survival, and tumor angiogenesis in transgene-induced
mammary tumor development. Cancer Res 2008;68:498 – 505.
24. Park HR, Tomida A, Sato S, et al. Effect on tumor cells of blocking survival
response to glucose deprivation. J Natl Cancer Inst 2004;96:1300 – 10.
25. Arap MA, Lahdenranta J, Mintz PJ, et al. Cell surface expression of the stress
response chaperone GRP78 enables tumor targeting by circulating ligands.
Cancer Cell 2004;6:275 – 84.
26. Davidson DJ, Haskell C, Majest S, et al. Kringle 5 of human plasminogen
induces apoptosis of endothelial and tumor cells through surface-expressed
glucose-regulated protein 78. Cancer Res 2005;65:4663 – 72.
27. Liu Y, Steiniger SC, Kim Y, Kaufmann GF, Felding-Habermann B, Janda
KD. Mechanistic studies of a peptidic GRP78 ligand for cancer cell-specific drug
delivery. Mol Pharmacol 2007;4:435 – 47.
28. Perri SR, Nalbantoglu J, Annabi B, et al. Plasminogen kringle 5-engineered
glioma cells block migration of tumor-associated macrophages and suppress
tumor vascularization and progression. Cancer Res 2005;65:8359 – 65.
29. Dong D, Ko B, Baumeister P, et al. Vascular targeting and antiangiogenesis
agents induce drug resistance effector GRP78 within the tumor microenvironment. Cancer Res 2005;65:5785 – 91.
